136 related articles for article (PubMed ID: 1732503)
1. The effect of antiviral therapy on the natural history of human immunodeficiency virus infection in a cohort of hemophiliacs.
Ragni MV; Kingsley LA; Zhou SJ
J Acquir Immune Defic Syndr (1988); 1992; 5(2):120-6. PubMed ID: 1732503
[TBL] [Abstract][Full Text] [Related]
2. Placebo-controlled trial to evaluate zidovudine in treatment of human immunodeficiency virus infection in asymptomatic patients with hemophilia. NHF-ACTG 036 Study Group.
Merigan TC; Amato DA; Balsley J; Power M; Price WA; Benoit S; Perez-Michael A; Brownstein A; Kramer AS; Brettler D
Blood; 1991 Aug; 78(4):900-6. PubMed ID: 1831059
[TBL] [Abstract][Full Text] [Related]
3. Survival of patients receiving zidovudine before or after AIDS diagnosis: results of a German multicenter study. German AIDS Study Group.
Clin Investig; 1994 Jan; 72(2):111-6. PubMed ID: 8186655
[TBL] [Abstract][Full Text] [Related]
4. A comparison of two dosing regimens of zidovudine in Thai adults with early symptomatic HIV infection. Conducting clinical HIV trials in South-East Asia.
Phanuphak P; Grayson ML; Sirivichayakul S; Suwanagool S; Ruxrungtham K; Hanvanich M; Ratanasuwan W; Ubolyam S; Hughes MD; Wanke CA; Hammer SM
Aust N Z J Med; 2000 Feb; 30(1):11-20. PubMed ID: 10800872
[TBL] [Abstract][Full Text] [Related]
5. The impact of antiviral therapy with zidovudine: a retrospective study on HIV-positive hemophiliacs in Italy. Italian Group of Congenital Coagulopathies.
Arcieri R; Puopolo M; Baudo F; Chiarotti F; De Rosa V; Schinaia N; Mori PG; Ghirardini A
Haematologica; 1995; 80(1):25-30. PubMed ID: 7758987
[TBL] [Abstract][Full Text] [Related]
6. [Progression to AIDS among HIV-seropositive hemophiliacs].
Lorenzo JI; Molina R; Senent ML; Monzó E; Lerma MA; Dasí MA; Monteagudo E; Aznar JA
Sangre (Barc); 1992 Jun; 37(3):169-74. PubMed ID: 1440093
[TBL] [Abstract][Full Text] [Related]
7. Phase II, randomized, open-label, community-based trial to compare the safety and activity of combination therapy with recombinant interferon-alpha2b and zidovudine versus zidovudine alone in patients with asymptomatic to mildly symptomatic HIV infection. HIV Protocol C91-253 Study Team.
Krown SE; Aeppli D; Balfour HH
J Acquir Immune Defic Syndr Hum Retrovirol; 1999 Mar; 20(3):245-54. PubMed ID: 10077172
[TBL] [Abstract][Full Text] [Related]
8. AIDS and hemophilia: experience in the La Paz Hemophilia Center.
Magallón Martínez M; Ortega F; Pinilla J
Haemostasis; 1992; 22(5):281-92. PubMed ID: 1362177
[TBL] [Abstract][Full Text] [Related]
9. CD4+ lymphocyte response to zidovudine as a predictor of AIDS-free time and survival time.
Graham NM; Piantadosi S; Park LP; Phair JP; Rinaldo CR; Fahey JL
J Acquir Immune Defic Syndr (1988); 1993 Nov; 6(11):1258-66. PubMed ID: 7901384
[TBL] [Abstract][Full Text] [Related]
10. Pneumocystis prophylaxis and survival in patients with advanced human immunodeficiency virus infection treated with zidovudine. The Zidovudine Epidemiology Group.
Chaisson RE; Keruly J; Richman DD; Moore RD
Arch Intern Med; 1992 Oct; 152(10):2009-13. PubMed ID: 1417373
[TBL] [Abstract][Full Text] [Related]
11. Antiretroviral treatment and progression to AIDS in HIV seroconverters from different risk groups. HIV Italian Seroconversion Study.
Dorrucci M; Pezzotti P; Phillips AN; Alliegro MB; Rezza G
AIDS; 1997 Mar; 11(4):461-7. PubMed ID: 9084793
[TBL] [Abstract][Full Text] [Related]
12. Progression of HIV disease in a haemophilic cohort followed for 11 years and the effect of treatment.
Lee CA; Phillips AN; Elford J; Janossy G; Griffiths P; Kernoff P
BMJ; 1991 Nov; 303(6810):1093-6. PubMed ID: 1781870
[TBL] [Abstract][Full Text] [Related]
13. Impact of treatment changes on the interpretation of the Concorde trial.
White IR; Walker S; Babiker AG; Darbyshire JH
AIDS; 1997 Jul; 11(8):999-1006. PubMed ID: 9223734
[TBL] [Abstract][Full Text] [Related]
14. A randomized study of combined zidovudine-lamivudine versus didanosine monotherapy in children with symptomatic therapy-naive HIV-1 infection. The Pediatric AIDS Clinical Trials Group Protocol 300 Study Team.
McKinney RE; Johnson GM; Stanley K; Yong FH; Keller A; O'Donnell KJ; Brouwers P; Mitchell WG; Yogev R; Wara DW; Wiznia A; Mofenson L; McNamara J; Spector SA
J Pediatr; 1998 Oct; 133(4):500-8. PubMed ID: 9787687
[TBL] [Abstract][Full Text] [Related]
15. Rate of CD4 cell decline and prediction of survival in zidovudine-treated patients.
Easterbrook PJ; Emami J; Gazzard B
AIDS; 1993 Oct; 7(10):959-67. PubMed ID: 7903542
[TBL] [Abstract][Full Text] [Related]
16. Pneumocystis carinii pneumonia prophylaxis and early clinical manifestations of severe perinatal human immunodeficiency virus type 1 infection. Northern California Pediatric HIV Consortium.
Maldonado YA; Araneta RG; Hersh AL
Pediatr Infect Dis J; 1998 May; 17(5):398-402. PubMed ID: 9613653
[TBL] [Abstract][Full Text] [Related]
17. Size and duration of zidovudine benefit in 1003 HIV-infected patients: U.S. Army, Navy, and Air Force natural history data. Military Medical Consortium for Applied Retroviral Research.
Gardner LI; Harrison SH; Hendrix CW; Blatt SP; Wagner KF; Chung RC; Harris RW; Cohn DL; Burke DS; Mayers DL
J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Apr; 17(4):345-53. PubMed ID: 9525436
[TBL] [Abstract][Full Text] [Related]
18. Effect of antiretroviral combination therapy (zidovudine/didanosine or zidovudine/lamivudine) on quantitative plasma human immunodeficiency virus-ribonucleic acid in children and adolescents infected with human immunodeficiency virus.
Sölder B; Wintergerst U; Notheis G; Eberle J; Gürtler L; Belohradsky BH
J Pediatr; 1997 Feb; 130(2):293-9. PubMed ID: 9042135
[TBL] [Abstract][Full Text] [Related]
19. Use of CD4 lymphocyte count to predict long-term survival free of AIDS after HIV infection.
Phillips AN; Sabin CA; Elford J; Bofill M; Janossy G; Lee CA
BMJ; 1994 Jul; 309(6950):309-13. PubMed ID: 7916226
[TBL] [Abstract][Full Text] [Related]
20. Racial and ethnic differences in outcome in zidovudine-treated patients with advanced HIV disease. Zidovudine Epidemiology Study Group.
Easterbrook PJ; Keruly JC; Creagh-Kirk T; Richman DD; Chaisson RE; Moore RD
JAMA; 1991 Nov; 266(19):2713-8. PubMed ID: 1942423
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
